Pluri Inc
PublicPluri Inc is now publicly traded
The data on this page reflects Pluri Inc's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
Feb 4, 2025
Total Funding Raised
$203.48M
Company Overview
Pluri Inc has raised $203.48M. It was founded in 2001.
Pluri Inc is a biotechnology company that develops cell-based products and therapeutics using a proprietary 3D cell expansion platform for industries including regenerative medicine, food technology, and agriculture.
AI Layer
Application
Pluri Inc Comparables
Compare Pluri Inc with similar companies based on industry and business-model similarity.
No comparables are published for Pluri Inc. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
Pluri Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Feb 4, 2025 | ||||
| Private Placement | Jan 23, 2025 | ||||
| Grant | Nov 10, 2021 | ||||
| Debt | May 25, 2021 | ||||
| Follow-on Offering | Feb 2, 2021 | ||||
Follow-on Offering | May 5, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pluri Inc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MJR PharmJet | Grant |
| European Commission (Horizon Europe) | Grant |
| H.C. Wainwright & Co. | Private Placement, Follow-on Offering |
| Israel Innovation Authority | Grant |
| Innovative Medical Management Co. Ltd. | Private Placement |
| European Investment Bank Group | Debt |
| Vall d'Hebron Research Institute | Grant |
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- promotesNov 2, 2026
Pluri Inc. promotes Yaky Yanay to CEO in Jun '19 after he serves as President since Feb '14.
- partners_withOct 26, 2026
On Oct 26th '26, Pluri Inc. and ZEO ScientifiX, Inc. announce a definitive strategic partnership to broaden regenerative medicine, aesthetics, wellness, and longevity products and strengthen selected clinical-development programs in Israel and Florida.
For institutional investors. Book with your work email.
Pluri Inc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.